Relpax vs. Neurontin: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Relpax and Neurontin. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 437,322 people who take Relpax and Neurontin, and is updated regularly.
What is Relpax?
Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
437,322 people who take Relpax and Neurontin are studied.
Drugs being compared in this study:
- Relpax (eletriptan hydrobromide)
- Neurontin (gabapentin)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Relpax:
- not at all: 2.02 %
- somewhat: 11.82 %
- moderate: 27.95 %
- high: 35.45 %
- very high: 22.77 %
Neurontin:
- not at all: 5.79 %
- somewhat: 29.59 %
- moderate: 35.55 %
- high: 21.11 %
- very high: 7.96 %
Want to compare Relpax with Neurontin?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Relpax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on eletriptan hydrobromide and gabapentin (the active ingredients of Relpax and Neurontin, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tacrolimus cause Pathogen Resistance? - now
- Erythromycin and Qvar drug interactions for women aged 50-59 - 5 seconds ago
- Could Quetiapine Fumarate cause Hepatic Necrosis? - 7 seconds ago
- Could Fluconazole cause Small Intestinal Perforation? - 15 seconds ago
- Pioglitazone vs. Vitamin D, side effect and effectiveness comparison - 31 seconds ago
- Could Esomeprazole Magnesium cause Ischaemic Stroke? - 35 seconds ago
- Drug interactions of Allegra D 24 Hour and Profen - 36 seconds ago
- Could Coq10 cause Upper Limb Fracture? - 38 seconds ago
- Drug interactions of Alginate and Lorazepam - 47 seconds ago
- Fibromyalgia in Vitamin B12, how severe and when it was recovered? - a minute ago